Offering the product as a tube presentation differentiating it from the bottle pump just might work as it will be competing against 5 other FDA approved and launched competitors. But the challenge will be gaining distribution for this to be a choice for the consumer and the track record to date has been abysmal.
Second, with all the Trump Tariff madness, being manufactured and packaged in the United States might be a benefit.
- Forums
- ASX - By Stock
- ACR
- Ann: Dapsone 7.5%, Gel launched in the United States
ACR
acrux limited
Add to My Watchlist
0.00%
!
1.8¢

Ann: Dapsone 7.5%, Gel launched in the United States, page-4
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $7.366M |
Open | High | Low | Value | Volume |
1.8¢ | 1.8¢ | 1.8¢ | $2.43K | 135K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 916823 | 1.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.0¢ | 427217 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 916823 | 0.017 |
10 | 1075173 | 0.016 |
6 | 1361882 | 0.015 |
2 | 140000 | 0.014 |
3 | 486850 | 0.013 |
Price($) | Vol. | No. |
---|---|---|
0.020 | 427217 | 5 |
0.021 | 111922 | 1 |
0.022 | 100000 | 1 |
0.023 | 381179 | 1 |
0.024 | 201073 | 3 |
Last trade - 11.05am 29/07/2025 (20 minute delay) ? |
Featured News
ACR (ASX) Chart |